Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance
| العنوان: | Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance |
|---|---|
| المؤلفون: | Shaghayegh Pezeshki, Payam Hashemi |
| المصدر: | Immunopharmacology and Immunotoxicology. 43:265-270 |
| بيانات النشر: | Informa UK Limited, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | 0301 basic medicine, endocrine system diseases, Immunology, Type 2 diabetes, Disease, Pharmacology, Toxicology, 03 medical and health sciences, 0302 clinical medicine, Immune system, Insulin resistance, Diabetes mellitus, medicine, Humans, Immunology and Allergy, Receptor, Dipeptidyl peptidase-4, SARS-CoV-2, business.industry, Drug Repositioning, General Medicine, medicine.disease, Metformin, COVID-19 Drug Treatment, 030104 developmental biology, Diabetes Mellitus, Type 2, 030220 oncology & carcinogenesis, Insulin Resistance, business, medicine.drug |
| الوصف: | Understanding the exact role of current drugs in Covid-19 disease is essential in the era of global pandemics. Metformin which prescribed as the first-line treatment of type 2 diabetes has beneficial effects on Sars-cov2 infection. These effects are including regulation of immune system, Renin-Angiotensin System and Dipeptidyl Peptidase 4 function in Covid-19 infection. It also activates ACE2, the main receptor of Sars-cov2, in the epithelial cells of respiratory tissue through AMPK signaling and subsequently decreases the rate of viral adhesion. Metformin also declines the adherence of Sars-cov2 to DPP4 (the other receptor of the virus) on T cells. Hence, regulatory effects of metformin on membranous ACE2, and DPP4 can modulate immune reaction against Sars-cov2. Also, immunometabolic effects of metformin on inflammatory cells impair hyper-reactive immune response against the virus through reduction of glycolysis and propagation of mitochondrial oxidation. Metformin also decreases platelet aggravation and risk of thrombosis. In this article, we argue that metformin has beneficial effects on Covid-19 infection in patients with type 2 diabetes and insulin resistance. This opinion should be investigated in future clinical trials. |
| تدمد: | 1532-2513 0892-3973 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a09f3444b7aaf19a9ac1d88609d65e https://doi.org/10.1080/08923973.2021.1925294 |
| رقم الأكسشن: | edsair.doi.dedup.....f0a09f3444b7aaf19a9ac1d88609d65e |
| قاعدة البيانات: | OpenAIRE |
PDF full text from Publisher | تدمد: | 15322513 08923973 |
|---|